Arcadia Biosciences (RKDA) Misses Q3 EPS by 118c

Arcadia Biosciences (NASDAQ: RKDA) reported Q3 EPS of ($1.18). Revenue for the quarter came in at $1.53 million.

For earnings history and earnings-related data on Arcadia Biosciences (RKDA) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• Lockheed Martin wins $2.8B in Defense contracts for F-35, helicopters
• 22nd Century Group files prospectus for warrant share resale